Table 2.5. Number and rates* of newly reported cases† of chronic hepatitis B virus infection, by state or jurisdiction — United States, 2019
* Rates per 100,000 population.
†For case definition, see https://ndc.services.cdc.gov/conditions/hepatitis-b-chronic/.
—: No reported cases. The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable. The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
U: Unavailable. The data were unavailable.
In the United States, chronic hepatitis B is one of the leading causes of cirrhosis, which is a major cause of liver cancer. This table displays the number and rates of newly identified chronic hepatitis B cases during 2019, by state or jurisdiction. Of note, cases of newly reported chronic hepatitis B do not represent all prevalent hepatitis B infections, which cannot be captured in the National Notifiable Diseases Surveillance System.
Of the 13,859 cases of chronic hepatitis B reported during 2019, approximately half of the cases were from 6 states (Florida, New York, Georgia, Pennsylvania, Ohio, and Tennessee). The highest rate of newly reported chronic hepatitis B was in Georgia (12.0 cases per 100,000 population, whereas the lowest rates were in Kansas and Wisconsin (0.9 cases per 100,000 population).
- Figure 2.1. Number of reported acute hepatitis B virus cases and estimated infections — United States, 2012–2019
- Figure 2.2. Rates of reported acute hepatitis B virus infection, by state — United States, 2018–2019
- Figure 2.3. Rates of reported acute hepatitis B virus infection, by state or jurisdiction — United States, 2019
- Figure 2.4. Rates of reported acute hepatitis B virus infection, by age group — United States, 2004–2019
- Figure 2.5. Rates of reported acute hepatitis B virus infection, by sex — United States, 2004–2019
- Figure 2.6. Rates of reported acute hepatitis B virus infections, by race/ethnicity — United States, 2004–2019
- Figure 2.7. Availability of information regarding risk behaviors or exposures associated with reported cases of acute hepatitis B virus infection — United States, 2019
- Figure 2.8. Rates of deaths with hepatitis B virus infection listed as a cause of death among residents, by jurisdiction — United States, 2019
- Table 2.1. Number and rates of reported cases of acute hepatitis B virus infection, by state or jurisdiction — United States, 2015–2019
- Table 2.2. Number and rates of reported cases of acute hepatitis B virus infection, by demographic characteristics — United States 2015–2019
- Table 2.3. Reported risk behaviors or exposures among reported cases of acute hepatitis B virus infection — United States, 2019
- Table 2.4. Number of newly reported cases of perinatal hepatitis B virus infection, by state or jurisdiction — United States, 2019
- Table 2.5. Number and rates of newly reported cases of chronic hepatitis B virus infection, by state or jurisdiction — United States, 2019
- Table 2.6. Number and rates of newly reported cases of chronic hepatitis B virus infection, by demographic characteristics — United States, 2019
- Table 2.7. Number and rates of deaths with hepatitis B virus infection listed as a cause of death among residents, by state or jurisdiction — United States, 2015–2019
- Table 2.8. Number and rates of deaths with hepatitis B virus infections listed as a cause of death among residents, by demographic characteristics — United States, 2015–2019